The “wonderful” development of plastics in the 1940s brought about a change in our lives and may have created an incessant, hidden danger to our health.
Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.